Inflammasome-targeted therapy might prevent adverse perinatal outcomes of recurrent chronic intervillositis of unknown etiologyAurélien Mattuizzi, Estibaliz Lazaro, Patrick Blanco et al.|Nature Communications|2024Cited by 17